Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease-Reference-Cited by-同舟云学术

Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease

Published:2016-01-22 Issue:2 Volume:91 Page:220-226
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Iwaki Noriko¹²,Fajgenbaum David C.³,Nabel Christopher S.³,Gion Yuka¹,Kondo Eisei⁴,Kawano Mitsuhiro⁵,Masunari Taro⁶,Yoshida Isao⁷,Moro Hiroshi⁸,Nikkuni Koji⁹,Takai Kazue⁹,Matsue Kosei¹⁰,Kurosawa Mitsutoshi¹¹,Hagihara Masao¹²,Saito Akio¹³,Okamoto Masataka¹⁴,Yokota Kenji¹⁵,Hiraiwa Shinichiro¹⁶,Nakamura Naoya¹⁶,Nakao Shinji¹⁷,Yoshino Tadashi¹,Sato Yasuharu¹¹⁵

Affiliation:

1. Department of Pathology; Okayama University Graduate School of Medicine, Dentistry and, Pharmaceutical Sciences; Okayama Japan

2. Department of Cellular Transplantation Biology (Hematology/Oncology and Respiratory Medicine), Division of Cancer Medicine; Graduate School of Medical Sciences Kanazawa University; Kanazawa Japan

3. Department of Medicine, Division of Hematology & Oncology, Raymond & Ruth Perelman School of Medicine; University of Pennsylvania; Philadelphia Pennsylvania

4. Department of General Medicine; Okayama University Graduate School of Medicine, Dentistry and, Pharmaceutical Sciences; Okayama Japan

5. Division of Rheumatology; Kanazawa University Hospital; Kanazawa Japan

6. Department of Hematology; Chugoku Central Hospital; Fukuyama Japan

7. Department of Hematologic Oncology; National Hospital Organization Shikoku Cancer Center; Matsuyama Japan

8. Division of Clinical Infection Control and Prevention; Niigata University Graduate School of Medical and Dental Sciences; Niigata Japan

9. Division of Hematology; Niigata City General Hospital; Niigata Japan

10. Division of Hematology and Oncology, Department of Medicine; Kameda Medical Center; Kamogawa Japan

11. Department of Hematology; National Hospital Organization Hokkaido Cancer Center; Sapporo Japan

12. Department of Hematology; Eiju General Hospital; Tokyo Japan

13. Department of Hematology; National Hospital Organization Nishigunma National Hospital; Shibukawa Japan

14. Department of Hematology and Medical Oncology; Fujita Health University School of Medicine; Toyoake Japan

15. Division of Pathophysiology; Okayama University Graduate School of Health Sciences; Okayama Japan

16. Department of Pathology; Tokai University School of Medicine; Kanagawa Japan

17. Cellular Transplantation Biology; Division of Medicine, Kanazawa University Institutes of Medical, Pharmaceutical, and Health Sciences; Kanazawa Japan

Publisher

Wiley

Subject

Hematology

Reference37 articles.

1. Localized mediastinal lymphnode hyperplasia resembling thymoma;Castleman;Cancer,1956

2. A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: Clinical findings and clinicopathologic correlations in 15 patients;Frizzera;J Clin Oncol,1985

3. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations;Keller;Cancer,1972

4. Surgery in Castleman's disease: A systematic review of 404 published cases;Talat;Ann Surg,2012

5. Fifty years of multicentric Castleman's disease;Waterston;Acta Oncol,2004

Cited by 221 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dysmorphic megakaryocytes in TAFRO syndrome: A case series from a single institute;Blood Cells, Molecules, and Diseases;2024-09

2. Idiopathic multicentric Castleman disease with marrow fibrosis and extramedullary hematopoiesis;European Journal of Haematology;2024-08-29

3. Idiopathic multicentric Castleman disease-TAFRO after COVID-19: A case report;Modern Rheumatology Case Reports;2024-08-23

4. Delayed diagnosis of TAFRO syndrome: A case report;Medicine;2024-08-02

5. Recurrent Cerebral Hemorrhaging with Platelet Dysfunction Accompanied by Anti-glycoprotein VI Autoantibodies in a Patient with TAFRO Syndrome;Internal Medicine;2024-07-01